These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 30498208)

  • 1. Obesity, altered oxidative stress, and clinical correlates in chronic schizophrenia patients.
    An H; Du X; Huang X; Qi L; Jia Q; Yin G; Xiao C; Huang XF; Ning Y; Cassidy RM; Wang L; Soares JC; Zhang XY
    Transl Psychiatry; 2018 Nov; 8(1):258. PubMed ID: 30498208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress in schizophrenia patients treated with long-acting haloperidol decanoate.
    Bošković M; Grabnar I; Terzič T; Kores Plesničar B; Vovk T
    Psychiatry Res; 2013 Dec; 210(3):761-8. PubMed ID: 24041751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Oxidative Stress Marker Levels in Unmedicated and Medicated Patients with Schizophrenia.
    Bai ZL; Li XS; Chen GY; Du Y; Wei ZX; Chen X; Zheng GE; Deng W; Cheng Y
    J Mol Neurosci; 2018 Nov; 66(3):428-436. PubMed ID: 30298298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered Antioxidant Defenses in Drug-Naive First Episode Patients with Schizophrenia Are Associated with Poor Treatment Response to Risperidone: 12-Week Results from a Prospective Longitudinal Study.
    Li XR; Xiu MH; Guan XN; Wang YC; Wang J; Leung E; Zhang XY
    Neurotherapeutics; 2021 Apr; 18(2):1316-1324. PubMed ID: 33791970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations of plasma oxidative stress levels in male patients with chronic schizophrenia. Correlations with psychopathology and matrix metalloproteinase-9: a case-control study.
    Yang H; Zhang C; Yang M; Liu J; Zhang Y; Liu D; Zhang X
    BMC Psychiatry; 2024 Jan; 24(1):20. PubMed ID: 38172869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interplay between BDNF and oxidative stress in chronic schizophrenia.
    Zhang XY; Chen DC; Tan YL; Tan SP; Wang ZR; Yang FD; Okusaga OO; Zunta-Soares GB; Soares JC
    Psychoneuroendocrinology; 2015 Jan; 51():201-8. PubMed ID: 25462893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics.
    Zhang XY; Tan YL; Cao LY; Wu GY; Xu Q; Shen Y; Zhou DF
    Schizophr Res; 2006 Jan; 81(2-3):291-300. PubMed ID: 16309894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine dependence, symptoms and oxidative stress in male patients with schizophrenia.
    Zhang XY; Tan YL; Zhou DF; Haile CN; Wu GY; Cao LY; Kosten TA; Kosten TR
    Neuropsychopharmacology; 2007 Sep; 32(9):2020-4. PubMed ID: 17228336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in oxidative stress markers in patients with schizophrenia: the effect of antipsychotic drugs.
    Tsai MC; Liou CW; Lin TK; Lin IM; Huang TL
    Psychiatry Res; 2013 Oct; 209(3):284-90. PubMed ID: 23497820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex difference in the association of body mass index and BDNF levels in Chinese patients with chronic schizophrenia.
    Yang F; Wang K; Du X; Deng H; Wu HE; Yin G; Ning Y; Huang X; Teixeira AL; de Quevedo J; Soares JC; Li X; Lang X; Zhang XY
    Psychopharmacology (Berl); 2019 Feb; 236(2):753-762. PubMed ID: 30456540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased Activity of Erythrocyte Catalase and Glutathione Peroxidase in Patients with Schizophrenia.
    Djordjević VV; Kostić J; Krivokapić Ž; Krtinić D; Ranković M; Petković M; Ćosić V
    Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant Enzymes and Weight Gain in Drug-naive First-episode Schizophrenia Patients Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study.
    Liu H; Yu R; Gao Y; Li X; Guan X; Thomas K; Xiu M; Zhang X
    Curr Neuropharmacol; 2022 Aug; 20(9):1774-1782. PubMed ID: 34544343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disrupted antioxidant enzyme activity and elevated lipid peroxidation products in schizophrenic patients with tardive dyskinesia.
    Zhang XY; Tan YL; Zhou DF; Cao LY; Wu GY; Haile CN; Kosten TA; Kosten TR
    J Clin Psychiatry; 2007 May; 68(5):754-60. PubMed ID: 17503985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there an interrelationship between the effects of antipsychotics on psychopathology and on metabolism?
    Chukhin E; Terevnikov V; Takala P; Hakko H; Putkonen H; Räsänen P; Stenberg JH; Eronen M; Joffe G
    Nord J Psychiatry; 2016; 70(3):190-4. PubMed ID: 26450657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of obesity and clinical and metabolic correlates in first-episode schizophrenia relative to healthy controls.
    Tian Y; Wang D; Wei G; Wang J; Zhou H; Xu H; Dai Q; Xiu M; Chen D; Wang L; Zhang XY
    Psychopharmacology (Berl); 2021 Mar; 238(3):745-753. PubMed ID: 33241480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in oxidative stress markers and its correlation with clinical findings in schizophrenic patients consuming perphenazine, clozapine and risperidone.
    Hendouei N; Farnia S; Mohseni F; Salehi A; Bagheri M; Shadfar F; Barzegar F; Hoseini SD; Charati JY; Shaki F
    Biomed Pharmacother; 2018 Jul; 103():965-972. PubMed ID: 29710513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex Differences in Body Mass Index and Obesity in Chinese Patients With Chronic Schizophrenia.
    Li Q; Chen D; Liu T; Walss-Bass C; de Quevedo JL; Soares JC; Zhao J; Zhang XY
    J Clin Psychopharmacol; 2016 Dec; 36(6):643-648. PubMed ID: 27811553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative-antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: effects of short term antipsychotic treatment.
    Sarandol A; Kirli S; Akkaya C; Altin A; Demirci M; Sarandol E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1164-9. PubMed ID: 17459548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free radicals, antioxidant defense systems, and schizophrenia.
    Wu JQ; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():200-6. PubMed ID: 23470289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.